SGMT Earnings Date: Nov 12, 2026 (Estimated) — Sagimet Biosciences Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is SGMT's next earnings date?
Sagimet Biosciences Inc. (SGMT) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.25 on revenue of $166,667.
How did SGMT do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Sagimet Biosciences Inc. posted EPS of -$0.26 versus the -$0.25 estimate, a miss of 3.7%. Revenue was $0. The stock's 1-day post-earnings move was -0.5%.
How much does SGMT stock move after earnings?
SGMT beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.7% (up or down) in the day after earnings.
About Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.25 | -0.26 | +3.70% | $0 | ❌ Miss | -0.52% | +8.99% | +13.48% |
| 2026-05-12 | Q1 2026 | -0.36 | -0.33 | +8.33% | $0 | ✅ Beat | -0.52% | -13.39% | -15.47% |
| 2026-03-11 | Q4 2025 | -0.41 | -0.29 | +29.27% | $0 | ✅ Beat | +3.80% | -6.15% | +1.99% |
| 2025-11-13 | Q3 2025 | -0.40 | -0.40 | +0.00% | $0 | ➖ Inline | -12.24% | -11.00% | -29.37% |
| 2025-08-13 | Q2 2025 | -0.51 | -0.32 | +37.25% | $0 | ✅ Beat | +0.31% | -27.64% | -26.28% |
| 2025-03-12 | Q4 2024 | -0.63 | -0.50 | +20.63% | $0 | ✅ Beat | +3.39% | +13.40% | -33.14% |
| 2024-11-13 | Q3 2024 | -0.42 | -0.45 | -7.14% | $0 | ❌ Miss | +1.35% | -25.76% | -23.57% |
| 2024-08-14 | Q2 2024 | -0.33 | -0.25 | +24.24% | $0 | ✅ Beat | -7.14% | +13.91% | +27.82% |
Showing last 8 quarters.